ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,000 | -63.6% | 8,085 | -20.1% | 0.00% | – |
| Q2 2023 | $22,000 | +57.1% | 10,124 | +44.6% | 0.00% | – |
| Q1 2023 | $14,000 | -33.3% | 7,003 | +24.4% | 0.00% | – |
| Q4 2022 | $21,000 | +133.3% | 5,630 | +182.8% | 0.00% | – |
| Q3 2022 | $9,000 | -25.0% | 1,991 | +33.5% | 0.00% | – |
| Q2 2022 | $12,000 | -7.7% | 1,491 | +67.3% | 0.00% | – |
| Q1 2022 | $13,000 | +30.0% | 891 | +86.0% | 0.00% | – |
| Q4 2021 | $10,000 | -58.3% | 479 | -45.4% | 0.00% | – |
| Q3 2021 | $24,000 | +100.0% | 877 | +83.9% | 0.00% | – |
| Q2 2021 | $12,000 | +9.1% | 477 | +11.7% | 0.00% | – |
| Q1 2021 | $11,000 | +1000.0% | 427 | +1840.9% | 0.00% | – |
| Q3 2020 | $1,000 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $40,911,000 | 7.12% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $36,944,000 | 3.67% |
| Burrage Capital Management LLC | 124,875 | $3,041,000 | 3.05% |
| Redmile Group, LLC | 7,522,029 | $183,161,000 | 2.71% |
| Indie Asset Partners, LLC | 91,641 | $2,231,000 | 1.81% |
| MPM BioImpact LLC | 218,027 | $5,309,000 | 0.87% |
| Ikarian Capital, LLC | 300,000 | $7,305,000 | 0.59% |
| Eventide Asset Management | 1,311,990 | $31,948,000 | 0.43% |
| Virtus ETF Advisers LLC | 21,540 | $524,000 | 0.22% |
| AlphaCentric Advisors LLC | 26,000 | $633,000 | 0.17% |